Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125991682 | 12599168 | 2 | F | 20160816 | 20160727 | 20160831 | EXP | US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-01313 | WESTWARD | 0.00 | F | Y | 0.00000 | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125991682 | 12599168 | 1 | PS | METHOTREXATE. | METHOTREXATE | 1 | Oral | Y | 40054 | ||||||||||
| 125991682 | 12599168 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | 0 | |||||||||||
| 125991682 | 12599168 | 3 | SS | ETANERCEPT | ETANERCEPT | 1 | Unknown | 0 | |||||||||||
| 125991682 | 12599168 | 4 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | 0 | |||||||||||
| 125991682 | 12599168 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 0 | |||||||||||
| 125991682 | 12599168 | 6 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | 0 | |||||||||||
| 125991682 | 12599168 | 7 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125991682 | 12599168 | 1 | Rheumatoid arthritis |
| 125991682 | 12599168 | 2 | Rheumatoid arthritis |
| 125991682 | 12599168 | 3 | Rheumatoid arthritis |
| 125991682 | 12599168 | 4 | Rheumatoid arthritis |
| 125991682 | 12599168 | 5 | Rheumatoid arthritis |
| 125991682 | 12599168 | 6 | Rheumatoid arthritis |
| 125991682 | 12599168 | 7 | Fibromyalgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125991682 | 12599168 | OT |
| 125991682 | 12599168 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125991682 | 12599168 | Abdominal pain upper | |
| 125991682 | 12599168 | Constipation | |
| 125991682 | 12599168 | Dry eye | |
| 125991682 | 12599168 | Eye disorder | |
| 125991682 | 12599168 | Gastrointestinal injury | |
| 125991682 | 12599168 | Hypersensitivity | |
| 125991682 | 12599168 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125991682 | 12599168 | 1 | 2012 | 2014 | 0 | |
| 125991682 | 12599168 | 2 | 2012 | 0 | ||
| 125991682 | 12599168 | 3 | 2012 | 2014 | 0 | |
| 125991682 | 12599168 | 4 | 2012 | 2014 | 0 | |
| 125991682 | 12599168 | 5 | 2012 | 2014 | 0 | |
| 125991682 | 12599168 | 6 | 2012 | 2014 | 0 | |
| 125991682 | 12599168 | 7 | 2013 | 0 |